Rheumatoid arthritis drug appears to help Covid patients in ICU
by Ian Sample Science editor from on (#5AKHA)
Trial suggests that tocilizumab improves outcomes for critically ill patients, say researchers
A drug used to treat rheumatoid arthritis appears to help patients who are admitted to intensive care with the most severe coronavirus infections, researchers say.
Tocilizumab, a medicine that dampens down inflammation, improved outcomes for critically ill patients, according to early results from an international trial investigating whether the drug and others like it boost survival rates and reduce the amount of time patients spend in intensive care.
Continue reading...